1/35
Looks like no tags are added yet.
The ACC/AHA guidelines continue to emphasize the importance of primary prevention of ACS by decreasing:
-CAD risk factors such as HTN, hypercholesterolemia, DM, smoking
-family history of CAD is also a risk factor
Atherosclerotic risk factors score calculators:
Framingham risk score
Pooled Cohort Equations
At the individual level, patients should be advised to do what at first recognition of ACS symptoms
chew a nonenteric coated aspirin (162 to 325 mg)
Electrocardiographic findings that may reflect myocardial ischemia include changes in what?
the PR segment, QRS complex, and the ST segment.1
_______is the recommended reperfusion method
Primary percutaneous coronary intervention (PCI)
The goal of medical management is to administer fibrinolytic therapy within _____ minutes
30
_______ is highly recommended in the treatment of STEMI to support primary PCI and fibrinolytic treatment strategies
Dual antiplatelet therapy
For patients undergoing primary PCI for STEMI, what should be given as early as possible?
clopidogrel 600 mg
When a patient has a stent, what should be given to them?
75 mg clopidogrel
Loading dose for clopidogrel requirements with PCI:
Should receive a loading dose of
clopidogrel 300 mg in persons younger than 75 years, or
75 mg in persons 75 years and older before treatment
In patients receiving fibrinolytic treatment, how should clopidogrel be given?
Clopidogrel, 75 mg per day, should be continued in patients receiving fibrinolytic treatment for at least 14 days and up to one year
Aggrastat
tirofiban
Integrilin
eptifibatide
Reopro
abciximab
Triple ____ therapy as been associated with an increased risk of bleeding
antiplatelet
_______ should also be initiated with either PCI or fibrinolytic therapy for the treatment of STEMI.
anticoagulation therapy
For patients undergoing PCI, ______ should be administered to maintain a therapeutic activated clotting time level.
unfractionated heparin or bivalirudin
________ should not be used as sole anticoagulation therapy in patients undergoing PCI because of the risk of catheter thrombosis
Fondaparinux (Arixtra)
For patients receiving fibrinolytic therapy for STEMI, _______ can be used as anticoagulation
Unfractionated heparin, enoxaparin (Lovenox), or fondaparinux can be used.
Treatment should be given for a minimum of _____and up to ______
48 hours and up to 8 days
Additional acute treatment options for ACS:
supplemental oxygen, nitroglycerin, intravenous morphine, beta blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and statins
When should oxygen saturation be appropriate?
when oxygen sat is less than 90%
What is the medication of choice for pain relief in STEMI patients?
morphine
_______ should be started within 24 hours in patients with STEMI or NSTE-ACS who do not have signs of heart failure, evidence of low output state, increased risk of cardiogenic shock, or other contraindications.
beta blockers
________ should be administered within the first 24 hours to all patients with heart failure, STEMI with anterior location, or ejection fraction less than 40%, in the absence of contraindications to therapy
Angiotensin-converting enzyme inhibitors
Continuing or initiating high-intensity statin therapy is recommended, even in patients with baseline low-density lipoprotein cholesterol levels less than ____
70 mg/dL
Lovenox dosing for fibrinolytic therapy:
If younger than 75 years: 30 mg IV bolus, followed in 15 minutes by 1 mg per kg subcutaneously every 12 hours (maximum 100 mg for the first two doses)
If 75 years or older: no bolus; 0.75 mg per kg subcutaneously every 12 hours (maximum 75 mg for the first two doses).
Regardless of age, if creatinine clearance < 30 mL per minute per 1.73 m2, 1 mg per kg subcutaneously every 24 hours
For the index hospitalization, continue up to eight days or until revascularization
Carvedilol dose for STEMI:
6.25 mg twice daily, titrate up to 25 mg as tolerated
Metoprolol IV dose STEMI:
5 mg every five minutes as tolerated, up to three doses
Metoprolol oral dose:
25 to 50 mg every six to 12 hours, eventually transitioning to twice daily or daily
Contraindications for beta blockers:
Contraindications to beta-blocker therapy include signs of heart failure, low output state, and risk of cardiogenic shock
Lisinopril dose ACS:
2.5 to 5 mg per day, titrate up to 10 mg as tolerated
The recommended goals for first medical contact to device time are _____ minutes for persons presenting to a PCI-capable hospital and ______ minutes for those presenting to a non-PCI-capable facility.
90
120
Fibronolytic therapy should be given to patients at a non-PCI facility if the time to PCI hospital exceeds what?
120 minutes
Evidence of failed reperfusion includes lack of resolution of what?
ST elevation and persistent or recurrent chest pain.
Absolute contraindications for fibrinolytic therapy patients with STEMI:
Any prior ICH
Known structural cerebral vascular lesion (e.g., arteriovenous malformation)
Known malignant intracranial neoplasm (primary or metastatic)
Ischemic stroke within three months, except acute ischemic stroke within 4.5 hours
Suspected aortic dissection
Active bleeding or bleeding diathesis (excluding menses)
Significant closed-head or facial trauma within three months
Intracranial or intraspinal surgery within two months Severe uncontrolled hypertension (unresponsive to emergency therapy)
For streptokinase, treatment within the previous six months